ergotamine has been researched along with Experimental Mammary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nasr, H; Pearson, OH | 1 |
| Bach, NJ; Clemens, JA; Kornfeld, EC; Owen, NV; Poore, GA; Sweeney, MJ | 1 |
2 other study(ies) available for ergotamine and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Inhibition of prolactin secretion by ergot alkaloids.
Topics: Animals; Depression, Chemical; Dihydroergotamine; Dihydroergotoxine; Ergolines; Ergot Alkaloids; Ergotamine; Estradiol; Estrus; Female; Mammary Neoplasms, Experimental; Perphenazine; Pituitary Gland; Pregnancy; Prolactin; Rats | 1975 |
Activity of 6-methyl-8-substituted ergolines against the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma.
Topics: Animals; Benz(a)Anthracenes; Carcinogens; Chemical Phenomena; Chemistry; Ergolines; Ergonovine; Ergot Alkaloids; Ergotamine; Female; Formamides; Mammary Neoplasms, Experimental; Prolactin; Rats | 1975 |